Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in IMVT — Immunovant, Inc.

CIK 1423053 MIAMI, FL
Back to IMVT Full portfolio

Position in IMVT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,586,846
-$340,721 QoQ
Shares Held
144,398
-6.5% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Derivatives in IMVT

reported options exposure · as of Mar 31, 2026
CallValue
$439,668
CallShares
17,700
PutValue
$1,371,168
PutShares
55,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,974,653 across 374 Biotechnology names. IMVT ranks #157 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in IMVT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,586,846 144,398
2026-03-31 $439,668 17,700
2026-03-31 $1,371,168 55,200
2025-12-31 $3,927,567 154,507
2025-12-31 $2,470,824 97,200
2025-12-31 $1,494,696 58,800
2025-09-30 $1,186,432 73,600
2025-09-30 $1,460,472 90,600
2025-09-30 $12,034,434 746,553
2025-06-30 $1,075,200 67,200
2025-06-30 $5,606,272 350,392
2025-06-30 $1,088,000 68,000
2025-03-31 $5,602,529 327,825
2025-03-31 $2,529,320 148,000
2025-03-31 $1,394,544 81,600
2024-12-31 $3,777,425 152,500
2024-12-31 $3,044,233 122,900
2024-12-31 $10,998,201 444,013
2024-09-30 $2,443,307 85,700
2024-09-30 $2,813,937 98,700
2024-09-30 $9,691,147 339,921
2024-06-30 $1,562,880 59,200
2024-06-30 $1,964,160 74,400
2024-06-30 $9,068,716 343,512
2024-03-31 $2,594,493 80,300
2024-03-31 $768,978 23,800
2024-03-31 $7,382,802 228,499
2023-12-31 $34,185,925 811,439
2023-12-31 $8,691,419 206,300
2023-12-31 $1,049,037 24,900
2023-09-30 $32,453,984 845,376
2023-09-30 $10,491,987 273,300
2023-09-30 $4,921,598 128,200
2023-06-30 $5,801,955 305,849
2023-06-30 $231,434 12,200
2023-06-30 $2,122,743 111,900
2023-03-31 $2,028,708 130,800
2023-03-31 $175,263 11,300
2023-03-31 $18,082,735 1,165,876
2022-12-31 $17,265,815 972,722
2022-12-31 $23,075 1,300
2022-12-31 $3,434,625 193,500
2022-09-30 $396,921 71,133
2022-09-30 $732,096 131,200
2022-06-30 $892,710 228,900
2022-06-30 $429,018 110,005
2022-03-31 $1,272,259 230,900
2022-03-31 $61,161 11,100
2022-03-31 $1,237,495 224,591
2021-12-31 $3,417,372 401,100

Report a Problem

Category
Description
Email (optional, for follow-up)